Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Classement en actions #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Prix de l'action
$0.1559364
Dernière synchronisation: 2026-09-18
Capitalisation boursière
$195.17K
Changement (1 jour)
6.60%
Changement (1 an)
-30.91%
Pays
GB
Échange Fusion Antibodies plc (FAB)

Catégorie

Historique du prix de l'action pour Fusion Antibodies plc (FAB)
Prix de clôture le plus élevé : $0.15 le 2026-09-01

Prix de clôture le plus bas : $2.40 le 2017-12-01
Historique du prix de l'action de Fusion Antibodies plc de 2017 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -10.83%
2025 153.72%
2024 39.11%
2023 -88.99%
2022 -66.99%
2021 -1.91%
2020 55.79%
2019 51.91%
2018 -71.85%
2017 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$509.53 32.99%
US
$991.92 34.63%
NL
$154.28 511.26%
US
$123.40 -5.68%
AU
$708.28 3.70%
CH